TP53 is a frequently mutated oncogene in human cancers, affecting the development of breast, lung, bladder, esophageal, prostate, pancreatic, and colorectal cancers and is involved in the normal physiology and metabolism of diabetes, liver, and cardiovascular diseases [40–44]. The gene discussed is TP53; the disease is cardiovascular disorder.